Research Topics
Species | Anthony W KimSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Innovations in thoracic surgeryAnthony W Kim
Section of Thoracic Surgery, Yale School of Medicine, New Haven, Connecticut 06520, USA
Curr Opin Anaesthesiol 26:13-9. 2013....- Additional pulmonary nodules in the patient with lung cancer: controversies and challengesAnthony W Kim
Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, 330 Cedar Street, BB 205, New Haven, CT 06520, USA
Clin Chest Med 32:811-25. 2011..This article focuses on the malignant additional pulmonary nodule in the same lobe as the known primary tumor, in a different lobe in the same lung as the known primary tumor, and in the contralateral lung... 
Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancerAnthony W Kim
Section of Thoracic Surgery, Department of Therapeutic Radiology and Radiation Oncology, Cancer Outcomes, Public Policy, and Effectiveness Research COPPER Center, Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, Connecticut 06520, USA
Ann Thorac Surg 94:895-901. 2012..However it is unclear how race, clinical, and hospital characteristics affect the surgical approach among patients undergoing resection...- An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancerAnthony W Kim
Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
J Thorac Cardiovasc Surg 143:55-63. 2012..Pneumonectomy after neoadjuvant therapy remains controversial... - Lymph node drainage patterns and micrometastasis in lung cancerAnthony W Kim
Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Semin Thorac Cardiovasc Surg 21:298-308. 2009..This manuscript reviews the patterns of lymph node drainage from a historical and current perspective to facilitate an understanding of the existing knowledge with respect to skip metastasis and micrometastasis... - Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancerAnthony W Kim
Section of Thoracic Surgery, Yale University School of Medicine, New Haven, CT 06520, United States
Lung Cancer 71:186-90. 2011..Lack of XOR expression is associated with unfavorable clinical outcomes. The objective of this study was to correlate XOR expression with prognosis in surgically resected non-small cell lung cancer (NSCLC)... - Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancerMichael T Vest
Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale Comprehensive Cancer Center, New Haven, Connecticut, USA
J Thorac Oncol 7:188-95. 2012..Studies have suggested that invasive mediastinal staging is underutilized, although practice patterns have not been rigorously evaluated... - Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patientsAnthony W Kim
Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
Ann Thorac Surg 92:233-41; discussion 241-3. 2011..This study evaluated patient survival after neoadjuvant chemoradiation and anatomic pulmonary resections for locoregionally advanced NSCLC... - Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing RegistryUsman Ahmad
Section of Thoracic Surgery, Department of Epidemiology, Yale University School of Public Health, New Haven, Connecticut 06520 8062, USA
Ann Thorac Surg 94:935-40; discussion 940-1. 2012..To compare outcomes of lung transplantation for advanced BAC, we studied this population in a compulsory, prospectively maintained database... - Use of new treatment modalities for non-small cell lung cancer care in the Medicare populationMichael T Vest
Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, New Haven, CT 06520, USA
Chest 143:429-35. 2013..The adoption of these techniques and their impact on access to cancer care among Medicare beneficiaries with stage I NSCLC are unknown... - Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomesHenry S Park
Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Ann Thorac Surg 93:372-9. 2012..Some previous analyses comparing VATS vs open lobectomy outcomes have been limited by inaccuracies in patient cohort identification... - Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic reviewAshok Muralidaran
Section of Thoracic Surgery, School of Medicine, Yale University, New Haven, Conn 06520, USA
J Thorac Cardiovasc Surg 142:1137-42. 2011..The objective of this study was to systematically review the long-term survival associated with the published studies dealing with the performance of lung resections for non-small cell lung cancer using circulatory bypass... - Stereotactic body radiotherapy for central lung tumorsBryan P Rowe
Department of Therapeutic Radiology, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut 06520, USA
J Thorac Oncol 7:1394-9. 2012..The primary purpose of this study was to assess toxicity in patients with central lesions treated with SBRT at our institution, the majority of whom were treated with four fractions... - Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?Daniel J Boffa
Department of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
J Thorac Oncol 5:1779-83. 2010..However, the staging system revision was not designed to evaluate treatment, and attempts to make parallel adjustments in treatment plans may not be justified...